CN106146376A - The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone - Google Patents

The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone Download PDF

Info

Publication number
CN106146376A
CN106146376A CN201510761451.1A CN201510761451A CN106146376A CN 106146376 A CN106146376 A CN 106146376A CN 201510761451 A CN201510761451 A CN 201510761451A CN 106146376 A CN106146376 A CN 106146376A
Authority
CN
China
Prior art keywords
tertbutyloxycarbonyl
methyl pyrrolidone
trans
synthetic method
medicine intermediate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510761451.1A
Other languages
Chinese (zh)
Inventor
彭海燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WUXI QIANHAO BIO-PHARMACEUTICAL Co Ltd
Original Assignee
WUXI QIANHAO BIO-PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WUXI QIANHAO BIO-PHARMACEUTICAL Co Ltd filed Critical WUXI QIANHAO BIO-PHARMACEUTICAL Co Ltd
Priority to CN201510761451.1A priority Critical patent/CN106146376A/en
Publication of CN106146376A publication Critical patent/CN106146376A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)

Abstract

The present invention relates to the synthetic method of a kind of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone, with pyrrolidones as raw material, first pass through and methylate, then, under 1.5 atmospheric pressure and etoh solvent effect, at temperature 150 DEG C-170 DEG C, trans tertbutyloxycarbonyl-2-methyl pyrrolidone is generated with butyrolactone ammonification.The synthetic method of medicine intermediate of the present invention trans tertbutyloxycarbonyl-2-methyl pyrrolidone is simple, efficient, and operates safety, very useful in concrete production.

Description

The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone
Technical field
The present invention relates to the synthetic method of a kind of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone.
Background technology
Trans tertbutyloxycarbonyl-2-methyl pyrrolidone is the initiation material of many pharmaceutical synthesis, the important intermediate of particularly a lot of pyrrolidone-2 compounds, the domestic at present synthetic method having no this compound of report.
Content of the invention
It is an object of the invention to overcome above-mentioned deficiency, provide a kind of simple, efficiently, the synthetic method of the medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone of safety operation.
The object of the present invention is achieved like this:
A kind of synthetic method of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone, with pyrrolidones as raw material, first pass through and methylate, then, under 1.5 atmospheric pressure and etoh solvent effect, at temperature 150 DEG C-170 DEG C, trans tertbutyloxycarbonyl-2-methyl pyrrolidone is generated with butyrolactone ammonification.
Compared with prior art, the invention has the beneficial effects as follows:
The synthetic method of medicine intermediate of the present invention trans tertbutyloxycarbonyl-2-methyl pyrrolidone is simple, efficient, and operates safety, very useful in concrete production.
Detailed description of the invention
The synthetic method of medicine intermediate of the present invention trans tertbutyloxycarbonyl-2-methyl pyrrolidone is specific as follows:
With pyrrolidones as raw material, first pass through and methylate, then under 1.5 atmospheric pressure and etoh solvent effect, at temperature 150 DEG C-170 DEG C, generate trans tertbutyloxycarbonyl-2-methyl pyrrolidone with butyrolactone ammonification.The purity of this crude product can meet general reaction requirement, can direct plunge in reaction.

Claims (1)

1. the synthetic method of a medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone, it is characterized in that with pyrrolidones as raw material, first pass through and methylate, then, under 1.5 atmospheric pressure and etoh solvent effect, at temperature 150 DEG C-170 DEG C, trans tertbutyloxycarbonyl-2-methyl pyrrolidone is generated with butyrolactone ammonification.
CN201510761451.1A 2015-11-11 2015-11-11 The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone Pending CN106146376A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510761451.1A CN106146376A (en) 2015-11-11 2015-11-11 The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510761451.1A CN106146376A (en) 2015-11-11 2015-11-11 The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone

Publications (1)

Publication Number Publication Date
CN106146376A true CN106146376A (en) 2016-11-23

Family

ID=57348124

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510761451.1A Pending CN106146376A (en) 2015-11-11 2015-11-11 The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone

Country Status (1)

Country Link
CN (1) CN106146376A (en)

Similar Documents

Publication Publication Date Title
MX2017009714A (en) Method for producing pyrazine carboxamide compound, and synthetic intermediate thereof.
CN106146376A (en) The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-2-methyl pyrrolidone
CN106117210A (en) The synthetic method of medicine intermediate hydroxyl 3-hydroxypyrrole pyrimidine
CN106117105A (en) The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-3-hydroxyethyl-pyrrolidone
CN106117106A (en) The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-3-ethyl pyrrolidone
CN106117107A (en) The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-4-methyl pyrrolidone
CN106117209A (en) The synthetic method of medicine intermediate trans tertbutyloxycarbonyl-4-pyrrolopyrimidine
CN106117208A (en) The synthetic method of medicine intermediate 5-ethoxy pyrrolopyrimidine
CN106146377A (en) The synthetic method of medicine intermediate 4-dimethylamino pyrrolidones
CN105753760A (en) A synthetic method of a medical intermediate N-boc-3-pyrrolidinone
CN105777605A (en) Synthetic method of medicine intermediate 3-hydroxypyrrolidone
CN106117108A (en) The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-3-methylpyrrole piperidines
CN106117102A (en) The synthetic method of medicine intermediate trans 3-t-butoxycarbonyl amino pyrrolidine
CN105777606A (en) Synthesis method of medicine intermediate 1-tert-butyloxycarboryl-2-cyanopyrrolidone
CN105753771A (en) A synthetic method of a medical intermediate trans-3-N-boc-aminopiperidine
CN106117103A (en) The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-3-(methoxymethyl-carbamyl) pyrrolidine
CN106117150A (en) The synthetic method of medicine intermediate trans 3-t-butoxycarbonyl amino piperazine
CN106146363A (en) The synthetic method of medical material 3-methyl sulfinic acid amine salt
CN106146382A (en) The synthetic method of medical material 2-methyl-L-tryptophan
CN106146289A (en) The synthetic method of medicine intermediate 4-oxo cyclobutane yl carboxylic acid salt
CN106117151A (en) The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-3-(methoxymethyl-carbamyl) piperazine
CN106146375A (en) The synthetic method of medicine intermediate 1-acetyl-4-(2-ethoxy) pyrrolidines
CN106146390A (en) The synthetic method of medicine intermediate 2-acetyl-4-(2-methyl) pyridine
CN106146273A (en) The synthetic method of medical material 2-ethyl-2-hydroxy-cyclohexanone
CN106146275A (en) The synthetic method of medical material 2-methyl-3-ethyl cyclohexanone

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20161123